Vantage Oncology Revenue and Competitors

Location

$74.5M

Total Funding

Estimated Revenue & Valuation

  • Vantage Oncology's estimated annual revenue is currently $72.9M per year.(i)
  • Vantage Oncology's estimated revenue per employee is $290,250
  • Vantage Oncology's total funding is $74.5M.

Employee Data

  • Vantage Oncology has 251 Employees.(i)
  • Vantage Oncology grew their employee count by -1% last year.

Vantage Oncology's People

NameTitleEmail/Phone
1
chief radiation therapistReveal Email/Phone
2
Director, Financial AccountingReveal Email/Phone
3
Director Clinical TechnologyReveal Email/Phone
4
Director Clinical ComplianceReveal Email/Phone
5
Director Revenue RecognitionReveal Email/Phone
6
Senior Manager, Nursing ServicesReveal Email/Phone
7
Medical DosimetristReveal Email/Phone
8
Radiation TherapistReveal Email/Phone
9
Medical PhysicistReveal Email/Phone
10
Medical PhysicistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is Vantage Oncology?

Founded in May 2002, Vantage Oncology Inc. develops and operates centers for the treatment of cancer utilizing the most advanced technology in radiation oncology. The company has an affiliation agreement with Valley Radiotherapy Associates (VRA) to provide clinicians, clinical systems and clinical treatment expertise. El Segundo, Calif.-based Vantage Oncology is led by a seasoned management team, including Chief Executive Officer Michael Fiore, Chief Development Officer/Chief Financial Officer Marshal Salomon, Vice President of Operations Milton Hinkle and Medical Director Leslie Botnick, MD The company’s board of directors includes Michael Aspinwall, Partner at Conning Capital Partners; Marty Felsenthal, General Partner at Salix Ventures; and Barbara Lubash, Managing Director at Versant Ventures; as well as Fiore and Botnick

keywords:N/A

$74.5M

Total Funding

251

Number of Employees

$72.9M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vantage Oncology News

2022-04-17 - Proof-of-Principle Study Points to Possibility of Monitoring ...

... a pediatrics, oncology, and computational biology researcher ... and patient-infectome interface provides a new vantage point from which...

2022-04-06 - BGL Welcomes Jonathan Bluth as a Managing Director in Healthcare & Life Sciences

He also held senior corporate finance positions with Vantage Oncology, Inc. and Alliance HealthCare Services.

2022-03-22 - Scilex Holding Company, a majority-owned subsidiary of ...

Scilex Holding Company and Vickers Vantage Corp. ... to fighting cancer is made possible by its extensive immuno-oncology platforms,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$59.5M26415%N/A
#2
$70M386N/AN/A
#3
$74.7M412-41%N/A
#4
$35M418-1%N/A
#5
N/A45929%N/A